Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000072.xml
Download PDF
Semin Reprod Med 2010; 28(6): 519-531
DOI: 10.1055/s-0030-1265680
© Thieme Medical PublishersDOI: 10.1055/s-0030-1265680
Ovarian Hyperstimulation Syndrome Prevention Strategies: In Vitro Maturation
Further Information
Publication History
Publication Date:
19 November 2010 (online)
ABSTRACT
The only reliable way to eliminate the risk of ovarian hyperstimulation syndrome (OHSS) is complete avoidance of gonadotropin ovarian stimulation. It could be argued that in vitro maturation (IVM) of oocytes represents the most effective strategy to prevent OHSS. IVM has been an established treatment option in many centers worldwide for over a decade. The use of IVM and natural cycle in vitro fertilization (IVF) combined with IVM can result in clinical pregnancy rates that compare to those obtained with conventional IVF. The obstetric and perinatal outcomes of IVM pregnancies are similar to those conceived from stimulated IVF or spontaneous conceptions. To date, more than a thousand healthy infants have been born without an increase in fetal abnormalities. Although IVM may not replace standard IVF, it plays an increasingly important role in assisted reproductive technology, especially in the settings of high responders and those patients at risk of OHSS.
KEYWORDS
In vitro maturation - ovarian hyperstimulation - immature oocyte
REFERENCES
- 1 de Mouzon J, Lancaster P, Nygren K G International Committee for Monitoring Assisted Reproductive Technology et al. World collaborative report on Assisted Reproductive Technology, 2002. Hum Reprod. 2009; 24(9) 2310-2320
- 2 Tan S L, Steer C, Royston P, Rizk P, Mason B A, Campbell S. Conception rates and in-vitro fertilisation. Lancet. 1990; 335(8684) 299
- 3 Tan S L, Royston P, Campbell S et al. Cumulative conception and live birth rates after in-vitro fertilisation. Lancet. 1992; 339(8806) 1390-1394
- 4 MacDougall M J, Tan S L, Jacobs H S. In-vitro fertilization and the ovarian hyperstimulation syndrome. Hum Reprod. 1992; 7(5) 597-600
- 5 MacDougall M J, Tan S L, Balen A, Jacobs H S. A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization. Hum Reprod. 1993; 8(2) 233-237
- 6 Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z, Caspi E. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv. 1989; 44(6) 430-440
- 7 Navot D, Bergh P A, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril. 1992; 58(2) 249-261
- 8 Cluroe A D, Synek B J. A fatal case of ovarian hyperstimulation syndrome with cerebral infarction. Pathology. 1995; 27(4) 344-346
- 9 Akdemir R, Uyan C, Emiroglu Y. Acute myocardial infarction secondary thrombosis associated with ovarial hyperstimulation syndrome. Int J Cardiol. 2002; 83(2) 187-189
- 10 Engmann L, Maconochie N, Sladkevicius P, Bekir J, Campbell S, Tan S L. The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology. Hum Reprod. 1999; 14(1) 167-171
- 11 Enskog A, Henriksson M, Unander M, Nilsson L, Brännström M. Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril. 1999; 71(5) 808-814
- 12 Whelan III J G, Vlahos N F. The ovarian hyperstimulation syndrome. Fertil Steril. 2000; 73(5) 883-896
- 13 Chen D, Burmeister L, Goldschlag D, Rosenwaks Z. Ovarian hyperstimulation syndrome: strategies for prevention. Reprod Biomed Online. 2003; 7(1) 43-49
- 14 Agrawal R, Conway G, Sladkevicius P et al. Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries. Fertil Steril. 1998; 70(4) 651-658
- 15 Agrawal R, Tan S L, Wild S et al. Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome. Fertil Steril. 1999; 71(2) 287-293
- 16 Lee T-H, Liu C-H, Huang C-C et al. Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum Reprod. 2008; 23(1) 160-167
- 17 European Recombinant LH Study Group . Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study. J Clin Endocrinol Metab. 2001; 86(6) 2607-2618
- 18 Ludwig M, Felberbaum R E, Devroey P et al. Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction. Arch Gynecol Obstet. 2000; 264(1) 29-32
- 19 Shaker A G, Zosmer A, Dean N, Bekir J S, Jacobs H S, Tan S L. Comparison of intravenous albumin and transfer of fresh embryos with cryopreservation of all embryos for subsequent transfer in prevention of ovarian hyperstimulation syndrome. Fertil Steril. 1996; 65(5) 992-996
- 20 Tan S L, Balen A, el Hussein E, Campbell S, Jacobs H S. The administration of glucocorticoids for the prevention of ovarian hyperstimulation syndrome in in vitro fertilization: a prospective randomized study. Fertil Steril. 1992; 58(2) 378-383
- 21 Brinsden P R, Wada I, Tan S L, Balen A, Jacobs H S. Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol. 1995; 102(10) 767-772
- 22 Buckett W, Chian R-C, Tan S L. Can we eliminate severe ovarian hyperstimulation syndrome? Not completely. Hum Reprod. 2005; 20(8) 2367, author reply 2367-2368
- 23 Chian R-C, Buckett W M, Abdul Jalil A K et al. Natural-cycle in vitro fertilization combined with in vitro maturation of immature oocytes is a potential approach in infertility treatment. Fertil Steril. 2004; 82(6) 1675-1678
- 24 Baker T G. Quantitative and cytological study of germ cells in human ovaries. Proc R Soc Lond B Biol Sci. 1963; 158 417-433
- 25 Faddy M J, Gosden R G, Gougeon A, Richardson S J, Nelson J F. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod. 1992; 7(10) 1342-1346
- 26 Gougeon A, Ecochard R, Thalabard J C. Age-related changes of the population of human ovarian follicles: increase in the disappearance rate of non-growing and early-growing follicles in aging women. Biol Reprod. 1994; 50(3) 653-663
- 27 Gougeon A. Dynamics of follicular growth in the human: a model from preliminary results. Hum Reprod. 1986; 1(2) 81-87
- 28 Baerwald A R, Adams G P, Pierson R A. A new model for ovarian follicular development during the human menstrual cycle. Fertil Steril. 2003; 80(1) 116-122
- 29 Baerwald A R, Adams G P, Pierson R A. Characterization of ovarian follicular wave dynamics in women. Biol Reprod. 2003; 69(3) 1023-1031
- 30 Pincus G, Enzmann E V. The comparative behavior of mammalian eggs in vivo and in vitro, I. The activation of ovarian eggs. J Exp Med. 1935; 62(5) 665-675
- 31 Trounson A, Anderiesz C, Jones G. Maturation of human oocytes in vitro and their developmental competence. Reproduction. 2001; 121(1) 51-75
- 32 Moor R M, Dai Y, Lee C, Fulka Jr J. Oocyte maturation and embryonic failure. Hum Reprod Update. 1998; 4(3) 223-236
- 33 Edwards R G. Maturation in vitro of mouse, sheep, cow, pig, rhesus monkey and human ovarian oocytes. Nature. 1965; 208(5008) 349-351
- 34 Edwards R G. Maturation in vitro of human ovarian oöcytes. Lancet. 1965; 2(7419) 926-929
- 35 Veeck L L, Wortham Jr J W, Witmyer J et al. Maturation and fertilization of morphologically immature human oocytes in a program of in vitro fertilization. Fertil Steril. 1983; 39(5) 594-602
- 36 Cha K Y, Koo J J, Ko J J, Choi D H, Han S Y, Yoon T K. Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte program. Fertil Steril. 1991; 55(1) 109-113
- 37 Jurema M W, Nogueira D. In vitro maturation of human oocytes for assisted reproduction. Fertil Steril. 2006; 86(5) 1277-1291
- 38 Chian R C, Buckett W M, Tan S L. In-vitro maturation of human oocytes. Reprod Biomed Online. 2004; 8(2) 148-166
- 39 Le Du A, Kadoch I J, Bourcigaux N et al. In vitro oocyte maturation for the treatment of infertility associated with polycystic ovarian syndrome: the French experience. Hum Reprod. 2005; 20(2) 420-424
- 40 Child T J, Abdul-Jalil A K, Tan S L. Embryo morphology, cumulative embryo score, and outcome in an oocyte in vitro maturation program. Fertil Steril. 2002; 77(2) 424-425
- 41 Mikkelsen A L, Andersson A M, Skakkebaek N E, Lindenberg S. Basal concentrations of oestradiol may predict the outcome of in-vitro maturation in regularly menstruating women. Hum Reprod. 2001; 16(5) 862-867
- 42 Tan S L, Child T J, Gulekli B. In vitro maturation and fertilization of oocytes from unstimulated ovaries: predicting the number of immature oocytes retrieved by early follicular phase ultrasonography. Am J Obstet Gynecol. 2002; 186(4) 684-689
- 43 Child T J, Sylvestre C, Pirwany I, Tan S L. Basal serum levels of FSH and estradiol in ovulatory and anovulatory women undergoing treatment by in-vitro maturation of immature oocytes. Hum Reprod. 2002; 17(8) 1997-2002
- 44 Elizur S E, Son W-Y, Yap R et al. Comparison of low-dose human menopausal gonadotropin and micronized 17beta-estradiol supplementation in in vitro maturation cycles with thin endometrial lining. Fertil Steril. 2009; 92(3) 907-912
- 45 Wynn P, Picton H M, Krapez J A, Rutherford A J, Balen A H, Gosden R G. Pretreatment with follicle stimulating hormone promotes the numbers of human oocytes reaching metaphase II by in-vitro maturation. Hum Reprod. 1998; 13(11) 3132-3138
- 46 Mikkelsen A L, Smith S D, Lindenberg S. In-vitro maturation of human oocytes from regularly menstruating women may be successful without follicle stimulating hormone priming. Hum Reprod. 1999; 14(7) 1847-1851
- 47 Mikkelsen A L, Lindenberg S. Benefit of FSH priming of women with PCOS to the in vitro maturation procedure and the outcome: a randomized prospective study. Reproduction. 2001; 122(4) 587-592
- 48 Suikkari A-M, Tulppala M, Tuuri T, Hovatta O, Barnes F. Luteal phase start of low-dose FSH priming of follicles results in an efficient recovery, maturation and fertilization of immature human oocytes. Hum Reprod. 2000; 15(4) 747-751
- 49 Lin Y-H, Hwang J-L, Huang L-W et al. Combination of FSH priming and hCG priming for in-vitro maturation of human oocytes. Hum Reprod. 2003; 18(8) 1632-1636
- 50 Chian R C, Gülekli B, Buckett W M, Tan S L. Priming with human chorionic gonadotropin before retrieval of immature oocytes in women with infertility due to the polycystic ovary syndrome. N Engl J Med. 1999; 341(21) 1624-1626, 1626
- 51 Yang S-H, Son W-Y, Yoon S-H, Ko Y, Lim J-H. Correlation between in vitro maturation and expression of LH receptor in cumulus cells of the oocytes collected from PCOS patients in HCG-primed IVM cycles. Hum Reprod. 2005; 20(8) 2097-2103
- 52 Willis D S, Watson H, Mason H D, Galea R, Brincat M, Franks S. Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation. J Clin Endocrinol Metab. 1998; 83(11) 3984-3991
- 53 Chian R C, Buckett W M, Tulandi T, Tan S L. Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome. Hum Reprod. 2000; 15(1) 165-170
- 54 Gulekli B, Buckett W M, Chian R-C, Child T J, Abdul-Jalil A K, Tan S L. Randomized, controlled trial of priming with 10,000 IU versus 20,000 IU of human chorionic gonadotropin in women with polycystic ovary syndrome who are undergoing in vitro maturation. Fertil Steril. 2004; 82(5) 1458-1459
- 55 Son W-Y, Chung J-T, Chian R-C et al. A 38 h interval between hCG priming and oocyte retrieval increases in vivo and in vitro oocyte maturation rate in programmed IVM cycles. Hum Reprod. 2008; 23(9) 2010-2016
- 56 Trounson A, Anderiesz C, Jones G M, Kausche A, Lolatgis N, Wood C. Oocyte maturation. Hum Reprod. 1998; 13(Suppl 3) 52-62 discussion 71-75
- 57 Cobo A C, Requena A, Neuspiller F et al. Maturation in vitro of human oocytes from unstimulated cycles: selection of the optimal day for ovum retrieval based on follicular size. Hum Reprod. 1999; 14(7) 1864-1868
- 58 Smith L C, Olivera-Angel M, Groome N P, Bhatia B, Price C A. Oocyte quality in small antral follicles in the presence or absence of a large dominant follicle in cattle. J Reprod Fertil. 1996; 106(2) 193-199
- 59 Chian R C, Tan S L. Maturational and developmental competence of cumulus-free immature human oocytes derived from stimulated and intracytoplasmic sperm injection cycles. Reprod Biomed Online. 2002; 5(2) 125-132
- 60 Son W Y, Chung J T, Demirtas E et al. Comparison of in-vitro maturation cycles with and without in-vivo matured oocytes retrieved. Reprod Biomed Online. 2008; 17(1) 59-67
- 61 Son W-Y, Chung J-T, Herrero B et al. Selection of the optimal day for oocyte retrieval based on the diameter of the dominant follicle in hCG-primed in vitro maturation cycles. Hum Reprod. 2008; 23(12) 2680-2685
- 62 Ge H-S, Huang X-F, Zhang W, Zhao J-Z, Lin J-J, Zhou W. Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome. Fertil Steril. 2008; 89(1) 98-103
- 63 Hreinsson J, Rosenlund B, Fridén B et al. Recombinant LH is equally effective as recombinant hCG in promoting oocyte maturation in a clinical in-vitro maturation programme: a randomized study. Hum Reprod. 2003; 18(10) 2131-2136
- 64 Zhang Z G, Zhao J H, Wei Z L, Cong L, Zhou P, Cao Y X. Human umbilical cord blood serum in culture medium on oocyte maturation in vitro. Arch Androl. 2007; 53(6) 303-307
- 65 Lin Y H, Hwang J L, Huang L W, Seow K M, Tzeng C R. Influence of serum from pregnant women and selected pregnancy hormones on in-vitro maturation of murine oocytes. Reprod Biomed Online. 2008; 16(5) 671-676
- 66 Nagy Z P, Cecile J, Liu J, Loccufier A, Devroey P, Van Steirteghem A. Pregnancy and birth after intracytoplasmic sperm injection of in vitro matured germinal-vesicle stage oocytes: case report. Fertil Steril. 1996; 65(5) 1047-1050
- 67 Hwang J L, Lin Y H, Tsai Y L. In vitro maturation and fertilization of immature oocytes: a comparative study of fertilization techniques. J Assist Reprod Genet. 2000; 17(1) 39-43
- 68 Söderström-Anttila V, Mäkinen S, Tuuri T, Suikkari A-M. Favourable pregnancy results with insemination of in vitro matured oocytes from unstimulated patients. Hum Reprod. 2005; 20(6) 1534-1540
- 69 Requena A, Neuspiller F, Cobo A C et al. Endocrinological and ultrasonographic variations after immature oocyte retrieval in a natural cycle. Hum Reprod. 2001; 16(9) 1833-1837
- 70 Child T J, Gulekli B, Sylvestre C, Tan S L. Ultrasonographic assessment of endometrial receptivity at embryo transfer in an in vitro maturation of oocyte program. Fertil Steril. 2003; 79(3) 656-658
- 71 Barnes F L, Crombie A, Gardner D K et al. Blastocyst development and birth after in-vitro maturation of human primary oocytes, intracytoplasmic sperm injection and assisted hatching. Hum Reprod. 1995; 10(12) 3243-3247
- 72 Son W Y, Park S J, Hyun C S, Lee W D, Yoon S H, Lim J H. Successful birth after transfer of blastocysts derived from oocytes of unstimulated woman with regular menstrual cycle after IVM approach. J Assist Reprod Genet. 2002; 19(11) 541-543
- 73 Son W-Y, Lee S-Y, Lim J-H. Fertilization, cleavage and blastocyst development according to the maturation timing of oocytes in in vitro maturation cycles. Hum Reprod. 2005; 20(11) 3204-3207
- 74 Child T J, Abdul-Jalil A K, Gulekli B, Tan S L. In vitro maturation and fertilization of oocytes from unstimulated normal ovaries, polycystic ovaries, and women with polycystic ovary syndrome. Fertil Steril. 2001; 76(5) 936-942
- 75 Trounson A, Wood C, Kausche A. In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients. Fertil Steril. 1994; 62(2) 353-362
- 76 Cha K Y, Chian R C. Maturation in vitro of immature human oocytes for clinical use. Hum Reprod Update. 1998; 4(2) 103-120
- 77 Andersen A N, Gianaroli L, Felberbaum R, de Mouzon J, Nygren K G. European IVF-monitoring programme (EIM) for the European Society of Human Reproduction and Embryology (ESHRE) . Assisted reproductive technology in Europe, 2002. Results generated from European registers by ESHRE. Hum Reprod. 2006; 21(7) 1680-1697
- 78 Gunby J, Daya S. IVF Directors Group of the Canadian Fertility and Andrology Society . Assisted reproductive technologies (ART) in Canada: 2003 results from the Canadian ART Register. Fertil Steril. 2007; 88(3) 550-559
- 79 Nargund G, Waterstone J, Bland J M, Philips Z, Parsons J, Campbell S. Cumulative conception and live birth rates in natural (unstimulated) IVF cycles. Hum Reprod. 2001; 16(2) 259-262
- 80 Lim J H, Park S Y, Park S H, Yoon S H, Yang S H, Chian R C.
Combination of natural cycle IVF with IVM as infertility treatment . In: Tan SL, Chian RC, Buckett WM In-Vitro Maturation of Human Oocytes: Basic Science to Clinical Application. London, United Kingdom; Informa Healthcare Press 2007: 353-360MissingFormLabel - 81 Lim J H, Yang S H, Chian R C. New alternative to infertility treatment for women without ovarian stimulation. Reprod Biomed Online. 2007; 14(5) 547-549
- 82 Chian R C, Chung J T, Downey B R, Tan S L. Maturational and developmental competence of immature oocytes retrieved from bovine ovaries at different phases of folliculogenesis. Reprod Biomed Online. 2002; 4(2) 127-132
- 83 Lim J-H, Yang S-H, Xu Y, Yoon S-H, Chian R-C. Selection of patients for natural cycle in vitro fertilization combined with in vitro maturation of immature oocytes. Fertil Steril. 2009; 91(4) 1050-1055
- 84 Fadini R, Dal Canto M B, Renzini M M et al. Predictive factors in in-vitro maturation in unstimulated women with normal ovaries. Reprod Biomed Online. 2009; 18(2) 251-261
- 85 Maher E R, Brueton L A, Bowdin S C et al. Beckwith-Wiedemann syndrome and assisted reproduction technology (ART). J Med Genet. 2003; 40(1) 62-64
- 86 Sutcliffe A G, Peters C J, Bowdin S et al. Assisted reproductive therapies and imprinting disorders—a preliminary British survey. Hum Reprod. 2006; 21(4) 1009-1011
- 87 DeBaun M R, Niemitz E L, Feinberg A P. Association of in vitro fertilization with Beckwith-Wiedemann syndrome and epigenetic alterations of LIT1 and H19. Am J Hum Genet. 2003; 72(1) 156-160
- 88 Gicquel C, Gaston V, Mandelbaum J, Siffroi J-P, Flahault A, Le Bouc Y. In vitro fertilization may increase the risk of Beckwith-Wiedemann syndrome related to the abnormal imprinting of the KCN1OT gene. Am J Hum Genet. 2003; 72(5) 1338-1341
- 89 Cox G F, Bürger J, Lip V et al. Intracytoplasmic sperm injection may increase the risk of imprinting defects. Am J Hum Genet. 2002; 71(1) 162-164
- 90 Ørstavik K H, Eiklid K, van der Hagen C B et al. Another case of imprinting defect in a girl with Angelman syndrome who was conceived by intracytoplasmic semen injection. Am J Hum Genet. 2003; 72(1) 218-219
- 91 Young L E, Fernandes K, McEvoy T G et al. Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culture. Nat Genet. 2001; 27(2) 153-154
- 92 Kerjean A, Couvert P, Heams T et al. In vitro follicular growth affects oocyte imprinting establishment in mice. Eur J Hum Genet. 2003; 11(7) 493-496
- 93 Cha K Y, Chung H M, Lee D R et al. Obstetric outcome of patients with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer. Fertil Steril. 2005; 83(5) 1461-1465
- 94 Söderström-Anttila V, Salokorpi T, Pihlaja M, Serenius-Sirve S, Suikkari A-M. Obstetric and perinatal outcome and preliminary results of development of children born after in vitro maturation of oocytes. Hum Reprod. 2006; 21(6) 1508-1513
- 95 Buckett W M, Chian R-C, Dean N L, Sylvestre C, Holzer H EG, Tan S L. Pregnancy loss in pregnancies conceived after in vitro oocyte maturation, conventional in vitro fertilization, and intracytoplasmic sperm injection. Fertil Steril. 2008; 90(3) 546-550
- 96 Jakubowicz D J, Iuorno M J, Jakubowicz S, Roberts K A, Nestler J E. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2002; 87(2) 524-529
- 97 Buckett W M, Chian R C, Holzer H, Dean N, Usher R, Tan S L. Obstetric outcomes and congenital abnormalities after in vitro maturation, in vitro fertilization, and intracytoplasmic sperm injection. Obstet Gynecol. 2007; 110(4) 885-891
- 98 Elizur S E, Chian R C, Pineau C A et al. Fertility preservation treatment for young women with autoimmune diseases facing treatment with gonadotoxic agents. Rheumatology (Oxford). 2008; 47(10) 1506-1509
- 99 Hourvitz A, Maman E, Brengauz M, Machtinger R, Dor J. In vitro maturation for patients with repeated in vitro fertilization failure due to “oocyte maturation abnormalities”. Fertil Steril. 2010; 94(2) 496-501
- 100 Child T J, Phillips S J, Abdul-Jalil A K, Gulekli B, Tan S L. A comparison of in vitro maturation and in vitro fertilization for women with polycystic ovaries. Obstet Gynecol. 2002; 100(4) 665-670
- 101 Lim K, Lee W, Lim J. IVM after interruption of COH for the prevention of OHSS. Fertil Steril. 2005; 84 S84-S85
- 102 Sauer M V, Paulson R J, Lobo R A. Rare occurrence of ovarian hyperstimulation syndrome in oocyte donors. Int J Gynaecol Obstet. 1996; 52(3) 259-262
- 103 Holzer H, Scharf E, Chian R-C, Demirtas E, Buckett W, Tan S L. In vitro maturation of oocytes collected from unstimulated ovaries for oocyte donation. Fertil Steril. 2007; 88(1) 62-67
- 104 Abdul-Jalil A K, Child T J, Phillips S, Dean N, Carrier S, Tan S L. Ongoing twin pregnancy after ICSI of PESA-retrieved spermatozoa into in-vitro matured oocytes: case report. Hum Reprod. 2001; 16(7) 1424-1426
- 105 Fuchinoue K, Nakajo Y, Yagi A, Takeda M, Kyono K. Successful pregnancy and delivery following combined treatment of in vitro maturation (IVM) and testicular sperm extraction (TESE): a case report. J Assist Reprod Genet. 2004; 21(10) 371-373
- 106 Yun Q, Ting F, Chen J et al. Pregnancies and births resulting from in vitro matured oocytes fertilized with testicular spermatozoa. J Assist Reprod Genet. 2005; 22(3) 133-136
- 107 Tournaye H, Liu J, Nagy Z et al. Intracytoplasmic sperm injection (ICSI): the Brussels experience. Reprod Fertil Dev. 1995; 7(2) 269-278 discussion 278-279
- 108 Ghazzawi I M, Sarraf M G, Taher M R, Khalifa F A. Comparison of the fertilizing capability of spermatozoa from ejaculates, epididymal aspirates and testicular biopsies using intracytoplasmic sperm injection. Hum Reprod. 1998; 13(2) 348-352
- 109 Ao A, Jin S, Rao D, Son W Y, Chian R C, Tan S L. First successful pregnancy outcome after preimplantation genetic diagnosis for aneuploidy screening in embryos generated from natural-cycle in vitro fertilization combined with an in vitro maturation procedure. Fertil Steril. 2006; 85(5) 1510, e9-e11
- 110 Li Y, Feng H-L, Cao Y-J et al. Confocal microscopic analysis of the spindle and chromosome configurations of human oocytes matured in vitro. Fertil Steril. 2006; 85(4) 827-832
- 111 Xu L, Wang Y, Zhou P, Cao Y X, Huang T H, Chian R C. Cytogenetic analysis of in vivo and in vitro matured oocytes derived from naturally cycling and stimulated mice. Syst Biol Reprod Med. 2008; 54(3) 155-162
- 112 Huang J YJ, Chen H Y, Park J YS, Tan S L, Chian R-C. Comparison of spindle and chromosome configuration in in vitro- and in vivo-matured mouse oocytes after vitrification. Fertil Steril. 2008; 90(4, Suppl) 1424-1432
- 113 Wang Y, Ock S A, Chian R C. Effect of gonadotrophin stimulation on mouse oocyte quality and subsequent embryonic development in vitro. Reprod Biomed Online. 2006; 12(3) 304-314
- 114 Wang X, Falcone T, Attaran M, Goldberg J M, Agarwal A, Sharma R K. Vitamin C and vitamin E supplementation reduce oxidative stress-induced embryo toxicity and improve the blastocyst development rate. Fertil Steril. 2002; 78(6) 1272-1277
- 115 Gardner D K, Lane M. Ex vivo early embryo development and effects on gene expression and imprinting. Reprod Fertil Dev. 2005; 17(3) 361-370
- 116 Katz-Jaffe M G, Linck D W, Schoolcraft W B, Gardner D K. A proteomic analysis of mammalian preimplantation embryonic development. Reproduction. 2005; 130(6) 899-905
- 117 Edwards R G.
Foreword . In: Tan SL, Chian RC, Buckett WM In Vitro Maturation of Human Oocytes: Basic Science to Clinical Application. London, United Kingdom; Informa 2006: xv-xxMissingFormLabel - 118 Siristatidis C S, Maheshwari A, Bhattacharya S. In vitro maturation in sub fertile women with polycystic ovarian syndrome undergoing assisted reproduction. Cochrane Database Syst Rev. 2009; 21(1) CD006606
Jack Y.J. HuangM.D.
The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell
Medical College
1305 York Avenue, 7th floor, New York, NY 10021
Email: jyh9005@med.cornell.edu